NARI continues to gain from its expanded product portfolio. However, continued loss at the operating level raises concern.
On Friday, the FDA classified a recall of Inari Medical Inc’s (NASDAQ:NARI) ClotTriever catheter as “most serious.” The ClotTriever XL Catheter is used to remove clots (thrombi) and blockages (emboli) from large blood vessels (10 to 28 mm) outside the heart, including the second-largest vein in the body, the vena cava. Inari Medical updated the use instructions for the ClotTriever XL catheter after discovering serious adverse events caused by the device becoming entrapped or blocking the lung ar
Inari Medical (NARI) issues urgent updates to ClotTriever XL Catheter instructions following the FDA's recall after reports of serious injuries and deaths.